Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Domino's Pizza
DPZ
US Stock MarketDetailed Quotes
PSTV Plus Therapeutics
- 0.9835
- +0.1965+24.97%
Close Apr 23 16:00 ET
- 0.9600
- -0.0235-2.39%
Pre 07:06 ET
16.72MMarket Cap-0.42P/E (TTM)
1.2200High0.8607Low24.06MVolume0.9100Open0.7870Pre Close25.34MTurnover153.77%Turnover RatioLossP/E (Static)17.00MShares2.670252wk High-1.87P/B15.39MFloat Cap0.240052wk Low--Dividend TTM15.64MShs Float7507.4985Historical High--Div YieldTTM45.65%Amplitude0.2400Historical Low1.0530Avg Price1Lot Size
Plus Therapeutics Stock Forum
Sign in to post a comment
$AGM Group (AGMH.US)$ 74.87%
$AgriFORCE Growing (AGRI.US)$ 26.40%
$Bolt Projects (BSLK.US)$ 52.35%
$Bit Origin (BTOG.US)$ 44.06%
$ENDRA Life Sciences (NDRA.US)$ 61.30%
$Onconetix (ONCO.US)$ 28.33%
$Plus Therapeutics (PSTV.US)$ 54.43%
$Qualigen Therapeutics (QLGN.US)$ 23.60%
$Sonoma Pharmaceuticals (SNOA.US)$ 36.46%
$AgriFORCE Growing (AGRI.US)$ 26.40%
$Bolt Projects (BSLK.US)$ 52.35%
$Bit Origin (BTOG.US)$ 44.06%
$ENDRA Life Sciences (NDRA.US)$ 61.30%
$Onconetix (ONCO.US)$ 28.33%
$Plus Therapeutics (PSTV.US)$ 54.43%
$Qualigen Therapeutics (QLGN.US)$ 23.60%
$Sonoma Pharmaceuticals (SNOA.US)$ 36.46%
27
4
$Plus Therapeutics (PSTV.US)$ what are you hiding ?
1
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
28
9
$Plus Therapeutics (PSTV.US)$
Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
Tuesday, 15th April at 7:30 am
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces the ...
Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
Tuesday, 15th April at 7:30 am
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces the ...
3
2
$Plus Therapeutics (PSTV.US)$ to the moon
2
$Plus Therapeutics (PSTV.US)$
For Plus Therapeutics, a micro-cap company with $10.8M market capitalization, these REYOBIQ data represent crucial validation for their lead asset and radiotherapeutic platform technology. The positive clinical signals in leptomeningeal metastases create a potential path forward in an indication with significant unmet need.
The 86% clinical benefit rate by physician evaluation and 75% by neuroimaging provide concrete efficacy signals that ...
For Plus Therapeutics, a micro-cap company with $10.8M market capitalization, these REYOBIQ data represent crucial validation for their lead asset and radiotherapeutic platform technology. The positive clinical signals in leptomeningeal metastases create a potential path forward in an indication with significant unmet need.
The 86% clinical benefit rate by physician evaluation and 75% by neuroimaging provide concrete efficacy signals that ...
1
$Plus Therapeutics (PSTV.US)$
The new data from Plus Therapeutics' ReSPECT-LM trial represents a meaningful development for patients with leptomeningeal metastases (LM) - one of the most challenging forms of cancer spread where tumor cells infiltrate the fluid and membranes surrounding the brain and spinal cord, typically carrying a dismal prognosis of weeks to months.
The 75% clinical benefit rate by neuroimaging (including 31% partial responses) is noteworthy...
The new data from Plus Therapeutics' ReSPECT-LM trial represents a meaningful development for patients with leptomeningeal metastases (LM) - one of the most challenging forms of cancer spread where tumor cells infiltrate the fluid and membranes surrounding the brain and spinal cord, typically carrying a dismal prognosis of weeks to months.
The 75% clinical benefit rate by neuroimaging (including 31% partial responses) is noteworthy...
No comment yet
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Mimi888 : Thank you always Dr.J
105181423 : Thank you, boss.
jimmy the trader : thanks J
かつやっチョッ : Thank you, teacher
I appreciate it 